|
🐢
|
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multice
40 auth.
S. Al-Batran,
R. Hofheinz,
C. Pauligk,
H. Kopp,
G. Haag,
K. Luley,
J. Meiler,
N. Homann,
S. Lorenzen,
H. Schmalenberg,
S. Probst,
M. Koenigsmann,
M. Egger,
N. Prasnikar,
K. Caca,
...
J. Trojan,
U. Martens,
A. Block,
W. Fischbach,
R. Mahlberg,
M. Clemens,
G. Illerhaus,
K. Zirlik,
D. Behringer,
W. Schmiegel,
M. Pohl,
M. Heike,
U. Ronellenfitsch,
M. Schuler,
W. Bechstein,
A. Königsrainer,
T. Gaiser,
P. Schirmacher,
W. Hozaeel,
Alexander Reichart,
T. Goetze,
M. Sievert,
E. Jäger,
S. Mönig,
A. Tannapfel
|
9 |
2016 |
9
🐢
|
|
🐜
|
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis1
10 auth.
H. Uhlig,
J. Coombes,
C. Mottet,
A. Izcue,
C. Thompson,
A. Fanger,
...
A. Tannapfel,
J. Fontenot,
F. Ramsdell,
F. Powrie
|
8 |
2006 |
8
🐜
|
|
🐜
|
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
9 auth.
M. Vogt,
J. Munding,
Martha Grüner,
Sven T. Liffers,
B. Verdoodt,
J. Hauk,
...
L. Steinstraesser,
A. Tannapfel,
H. Hermeking
|
8 |
2011 |
8
🐜
|
|
🐜
|
Surgical and Palliative Management and Outcome in 184 Patients With Hilar Cholangiocarcinoma: Palliative Photodynamic Therapy Plus Stenting Is Comparable to R1/R2 Resection
11 auth.
H. Witzigmann,
F. Berr,
U. Ringel,
K. Caca,
D. Uhlmann,
K. Schoppmeyer,
...
A. Tannapfel,
C. Wittekind,
J. Mossner,
J. Hauss,
M. Wiedmann
|
8 |
2006 |
8
🐜
|
|
🐜
|
Epigenetic silencing of the PTEN gene in melanoma.
7 auth.
A. Mirmohammadsadegh,
A. Marini,
S. Nambiar,
Mohamed Hassan,
A. Tannapfel,
T. Ruzicka,
...
U. Hengge
|
8 |
2006 |
8
🐜
|
|
🐜
|
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
17 auth.
S. Hegewisch‐Becker,
U. Graeven,
C. Lerchenmüller,
B. Killing,
R. Depenbusch,
C. Steffens,
S. Al-Batran,
T. Lange,
G. Dietrich,
J. Stoehlmacher,
...
A. Tannapfel,
A. Reinacher-Schick,
J. Quidde,
T. Trarbach,
A. Hinke,
H. Schmoll,
D. Arnold
|
7 |
2015 |
7
🐜
|
|
🐜
|
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
10 auth.
D. Sorger,
M. Patt,
Piyush Kumar,
L. Wiebe,
H. Barthel,
A. Seese,
...
C. Dannenberg,
A. Tannapfel,
R. Kluge,
O. Sabri
|
7 |
2003 |
7
🐜
|
|
🐜
|
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.
15 auth.
A. Szafranska,
M. Doleshal,
Hayward S Edmunds,
S. Gordon,
J. Lűttges,
J. Munding,
R. Barth,
E. Gutmann,
A. Suriawinata,
J. Marc Pipas,
...
A. Tannapfel,
M. Korc,
S. Hahn,
E. Labourier,
G. Tsongalis
|
7 |
2008 |
7
🐜
|
|
🐜
|
Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival
9 auth.
F. Berr,
M. Wiedmann,
A. Tannapfel,
U. Halm,
K. Kohlhaw,
F. Schmidt,
...
C. Wittekind,
J. Hauss,
J. Mössner
|
7 |
2000 |
7
🐜
|
|
🐢
|
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition
9 auth.
A. Weber,
U. Hengge,
W. Bardenheuer,
I. Tischoff,
F. Sommerer,
Annett Markwarth,
...
A. Dietz,
C. Wittekind,
A. Tannapfel
|
7 |
2005 |
7
🐢
|
|
🐜
|
Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma
9 auth.
M. Wiedmann,
K. Caca,
F. Berr,
I. Schiefke,
A. Tannapfel,
C. Wittekind,
...
J. Mössner,
J. Hauss,
H. Witzigmann
|
7 |
2003 |
7
🐜
|
